Invasive pneumococcal disease in UK children< 1 year of age in the post–13-valent pneumococcal conjugate vaccine era: what are the risks now?
A Kent, A Makwana, CL Sheppard… - Clinical Infectious …, 2019 - academic.oup.com
Background Invasive pneumococcal disease (IPD) has declined significantly since the
introduction of pneumococcal conjugate vaccines (PCVs). It is not known whether certain …
introduction of pneumococcal conjugate vaccines (PCVs). It is not known whether certain …
Characteristics of children with invasive pneumococcal disease after the introduction of the 13-valent pneumococcal conjugate vaccine in England and Wales, 2010 …
A Makwana, C Sheppard, R Borrow, N Fry… - The Pediatric …, 2018 - journals.lww.com
Background: In England and Wales, replacement of childhood 7-valent pneumococcal
conjugate vaccine (PCV7) with a 13-valent vaccine (PCV13) in 2010 was associated with a …
conjugate vaccine (PCV7) with a 13-valent vaccine (PCV13) in 2010 was associated with a …
Characteristics and serotype distribution of childhood cases of invasive pneumococcal disease following pneumococcal conjugate vaccination in England and Wales …
G Oligbu, S Collins, N Andrews… - Clinical Infectious …, 2017 - academic.oup.com
Abstract Background The 7-valent and 13-valent pneumococcal conjugate vaccines (PCV7
and PCV13, respectively) are highly effective in preventing invasive pneumococcal disease …
and PCV13, respectively) are highly effective in preventing invasive pneumococcal disease …
Impact of the 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in infants younger than 90 days in England and Wales
Background. Streptococcus pneumoniae is an uncommon but well-recognized cause of
invasive bacterial disease in young infants. This study aimed to determine the impact of the …
invasive bacterial disease in young infants. This study aimed to determine the impact of the …
[HTML][HTML] Similar impact and replacement disease after pneumococcal conjugate vaccine introduction in hospitalised children with invasive pneumococcal disease in …
AA Palmu, P De Wals, M Toropainen, SN Ladhani… - Vaccine, 2021 - Elsevier
High incidence of childhood invasive pneumococcal disease (IPD) in the US declined
steeply after 7-valent pneumococcal conjugate vaccine (PCV7) introduction, outweighing …
steeply after 7-valent pneumococcal conjugate vaccine (PCV7) introduction, outweighing …
Dynamics of invasive pneumococcal disease in Israel in children and adults in the 13-valent pneumococcal conjugate vaccine (PCV13) era: a nationwide prospective …
S Ben-Shimol, G Regev-Yochay… - Clinical Infectious …, 2022 - academic.oup.com
Background Following 13-valent pneumococcal conjugate vaccine (PCV13) implementation
in infants worldwide, overall and vaccine-type invasive pneumococcal disease (IPD) rates …
in infants worldwide, overall and vaccine-type invasive pneumococcal disease (IPD) rates …
Childhood deaths attributable to invasive pneumococcal disease in England and Wales, 2006–2014
G Oligbu, S Collins, CL Sheppard… - Clinical Infectious …, 2017 - academic.oup.com
Abstract Background Pneumococcal conjugate vaccines (PCVs) are highly effective in
preventing invasive pneumococcal disease (IPD), but deaths due to IPD still occur. We …
preventing invasive pneumococcal disease (IPD), but deaths due to IPD still occur. We …
Effectiveness of 7-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in medically at-risk children in Australia: a record linkage study
Background Children with chronic medical conditions are at higher risk of invasive
pneumococcal disease (IPD), but little is known about the effectiveness of the primary …
pneumococcal disease (IPD), but little is known about the effectiveness of the primary …
[HTML][HTML] Invasive pneumococcal disease after routine pneumococcal conjugate vaccination in children, England and Wales
SN Ladhani, MPE Slack, NJ Andrews… - Emerging infectious …, 2013 - ncbi.nlm.nih.gov
We assessed known risk factors, clinical presentation, and outcome of invasive
pneumococcal disease (IPD) in children 3–59 months of age after introduction of the 7 …
pneumococcal disease (IPD) in children 3–59 months of age after introduction of the 7 …
Twelve years of pneumococcal conjugate vaccination in the Netherlands: Impact on incidence and clinical outcomes of invasive pneumococcal disease
SMT Vestjens, EAM Sanders, BJ Vlaminckx… - Vaccine, 2019 - Elsevier
Abstract Introduction In 2006, the Netherlands introduced the 7-valent pneumococcal
conjugate vaccine (PCV7) in their national immunisation programme. In 2011, PCV7 was …
conjugate vaccine (PCV7) in their national immunisation programme. In 2011, PCV7 was …